Dendrobium nobile, a species of orchid native to South-east Asia, has been revered in traditional medicine systems for centuries due to its medicinal properties and therapeutic benefits. With a rich history in Chinese medicine and other traditional healing practices, there is now much interest in the chemical constituents of this orchid and potential applications for various health conditions. The aim of this book is to bridge the gap between the traditional knowledge surrounding this remarkable plant and the cutting-edge scientific investigations that have shed light on its pharmacological activities. It includes: · An overview of Dendrobium nobile, exploring its historical use in traditional medicine and its significance in various cultures. · Information on the chemical constituents, pharmacological activities, antioxidant properties and potential role in alleviating pain, inflammation, and respiratory diseases. · Therapeutic applications: immune enhancement, management of chronic conditions like diabetes and cardiovascular issues, gastrointestinal disorders, renal diseases, neuroprotection and skin health. · Safety and toxicity issues. · Sustainable practices and conservation of Dendrobium nobile, and the importance of preserving biodiversity.

Medicinal plants produce a huge range of specialized metabolites (or phytochemicals) with bioactive properties often in response to environmental cues or stresses. Some of these molecules have the potential to be exploited as pharmaceuticals. Omics-Driven Research in Medicinal Plants explores the transformative role of omics technologies - genomics, transcriptomics, proteomics, metabolomics, and epigenomics - in unlocking the therapeutic potential of medicinal plants. These technologies offer powerful tools for understanding and controlling the genetic and biological aspects of medicinal plants. Its scope spans foundational omics principles, multi-omics integration, precision breeding, metabolic engineering, and emerging frontiers such as AI-driven drug design and CRISPR-omics. By emphasizing sustainability, the book addresses climate-resilient cultivation, ethical bioprospecting, and conservation strategies, while advancing applications in drug discovery, functional foods, and ethnopharmacology. Researchers in medicinal plants, plant biotechnology, pharmacognosy, and systems biology, as well as policymakers and industry practitioners, will find this of value.

Dendrobium nobile, a species of orchid native to South-east Asia, has been revered in traditional medicine systems for centuries due to its medicinal properties and therapeutic benefits. With a rich history in Chinese medicine and other traditional healing practices, there is now much interest in the chemical constituents of this orchid and potential applications for various health conditions. The aim of this book is to bridge the gap between the traditional knowledge surrounding this remarkable plant and the cutting-edge scientific investigations that have shed light on its pharmacological activities. It includes: · An overview of Dendrobium nobile, exploring its historical use in traditional medicine and its significance in various cultures. · Information on the chemical constituents, pharmacological activities, antioxidant properties and potential role in alleviating pain, inflammation, and respiratory diseases. · Therapeutic applications: immune enhancement, management of chronic conditions like diabetes and cardiovascular issues, gastrointestinal disorders, renal diseases, neuroprotection and skin health. · Safety and toxicity issues. · Sustainable practices and conservation of Dendrobium nobile, and the importance of preserving biodiversity.

Medicinal plants produce a huge range of specialized metabolites (or phytochemicals) with bioactive properties often in response to environmental cues or stresses. Some of these molecules have the potential to be exploited as pharmaceuticals. Omics-Driven Research in Medicinal Plants explores the transformative role of omics technologies - genomics, transcriptomics, proteomics, metabolomics, and epigenomics - in unlocking the therapeutic potential of medicinal plants. These technologies offer powerful tools for understanding and controlling the genetic and biological aspects of medicinal plants. Its scope spans foundational omics principles, multi-omics integration, precision breeding, metabolic engineering, and emerging frontiers such as AI-driven drug design and CRISPR-omics. By emphasizing sustainability, the book addresses climate-resilient cultivation, ethical bioprospecting, and conservation strategies, while advancing applications in drug discovery, functional foods, and ethnopharmacology. Researchers in medicinal plants, plant biotechnology, pharmacognosy, and systems biology, as well as policymakers and industry practitioners, will find this of value.